
Medi Assist Stock Prediction 2026: Expert Analysis, Forecast Scenarios and Full Stock Review
Medi Assist (NSE:MEDIASSIST) CMP: Rs 365.2 (2026). 52W High: Rs 594. 52W Low: Rs 293. MCap: Rs 2,729 Cr. P/E: 52.4. Sector: Healthcare Services and Hospitals. JM Financial: Buy Rs 438. ICICI Securi…
Updated: 19 Jun 2026 • 10:09 am
Posted by:

The Medi Assist stock prediction for 2026 from leading brokerages covers a range reflecting sector dynamics, earnings trajectory and the macro environment. All estimates may or may not be achieved. Treat any Medi Assist share price prediction as one data point and not as a guarantee of future performance.
This article reviews every dimension of the Medi Assist stock forecast analysts are tracking, including key drivers, bull and bear scenarios and the primary risks. Verify all figures with the latest brokerage reports before any investment decision.
Click Here – Get Free Investment Predictions
What Analysts Predict for Medi Assist Stock in 2026
Analyst consensus on the Medi Assist stock prediction for 2026 is tracked by leading brokerages. The table below shows the latest available data from JM Financial and ICICI Securities. All figures are sourced from publicly available research and should be verified before publishing.
| Brokerage | Rating | Medi Assist Stock Prediction (Rs) | Updated |
|---|---|---|---|
| JM Financial | Buy | Rs 438 | 2026 |
| ICICI Securities | Neutral | Rs 404 | 2026 |
| Analyst Consensus | — | Rs 421 | 2026 |
The analyst target range for Medi Assist reflects genuine difference of opinion on demand recovery, margin trajectory and sector headwinds. The implied upside in the Medi Assist stock forecast from the current price of Rs 365.2 may or may not be realised by end of 2026.
3 Stocks Building Serious Momentum Right Now
When Univest analysts identify high-conviction stock opportunities, investors pay attention.
Our research team has shortlisted the Top Stocks to Buy based on current market momentum, sector trends & growth potential for 2026.
- Discover stocks investors are actively accumulating
- High-conviction opportunities backed by research
- Designed for the next phase of market growth
Unlock the latest Top Stock Picks now on Univest
Medi Assist Company Overview
Medi Assist Healthcare Services is a leading healthcare services provider operating hospitals, diagnostics or specialty facilities across India. The Medi Assist stock prediction for 2026 reflects structural growth in healthcare demand and operating leverage from bed expansion.
| Metric | Value |
|---|---|
| NSE Ticker | MEDIASSIST |
| Sector | Healthcare Services and Hospitals |
| CMP | Rs 365.2 (2026) |
| 52 Week High | Rs 594 |
| 52 Week Low | Rs 293 |
| Market Cap | Rs 2,729 Cr |
| P/E Ratio | 52.4 |
| Medi Assist Stock Prediction Consensus (12M) | Rs 421 |
Medi Assist Stock Prediction by Time Horizon
Analysts split the Medi Assist share price prediction across time frames as near-term drivers differ materially from the long-term view.
Short-Term Medi Assist Stock Prediction
The near-term Medi Assist stock forecast reflects current sentiment, sector news and upcoming earnings prints. Key support and resistance levels around Rs 365.2 are being watched closely. A short-term Medi Assist share price prediction carries the most uncertainty of any time horizon.
12-Month Medi Assist Stock Prediction
JM Financial targets Rs 438 (Buy) and ICICI Securities targets Rs 404 (Neutral). Most desks refresh their Medi Assist stock forecast within two to four weeks of each quarterly earnings print. The Medi Assist share price prediction should be verified against the most recent analyst reports.
Long-Term Medi Assist Stock Prediction
The long-term outlook for Medi Assist is built on assumptions about demand recovery, margin expansion and revenue diversification in the Healthcare Services and Hospitals sector. Long-term price targets carry the most uncertainty and should be treated as directional guidance only.
Medi Assist Stock Forecast: Key Factors
The following four factors appear consistently in analyst research on Medi Assist and are the primary inputs into the bull and bear case scenarios.
Bed Addition and Occupancy
Hospital bed additions and occupancy rates are the primary metrics in the Medi Assist stock forecast. Analysts look for occupancy above 65 percent as the basis for a higher Medi Assist share price prediction.
Revenue per Occupied Bed
Revenue per occupied bed improvement reflects the shift to higher-margin specialties. Analysts revise the Medi Assist share price prediction upward when per-bed revenue grows consistently.
EBITDA Margin Maturity
A portfolio shift toward mature hospitals supports the bullish Medi Assist stock prediction, while new hospital ramp-ups dilute margins in the near term.
International Patient Revenue
Medical tourism revenue provides premium pricing and diversifies the revenue base, supporting the Medi Assist stock forecast and premium valuation.
Medi Assist Stock Prediction: Bull and Bear Scenarios
| Scenario | Medi Assist Stock Prediction | Key Conditions |
|---|---|---|
| Bull Case | Rs 438 | Strong execution, margin improvement, favourable macro and sector re-rating |
| Base Case | Rs 421 | Steady performance, gradual recovery, margins hold, growth on track |
| Bear Case | Rs 293 | Demand deterioration, margin pressure, sector de-rating and macro headwinds |
The bull case Medi Assist stock forecast of Rs 438 assumes most positive variables converge. The base case of Rs 421 is the analyst consensus and may or may not be achieved.
How Analysts Are Reading the Medi Assist Stock Story
Analyst reviews of the Medi Assist share price prediction highlight the company’s core strengths in Healthcare Services and Hospitals alongside near-term headwinds from macro uncertainty, competitive pressure and sector-level challenges. Overall the analyst consensus for Medi Assist is built on real business strengths set against real risks.
Key Risks to the Medi Assist Stock Prediction
New Hospital Ramp-Up Costs
New hospital investments have multi-year ramp-up periods during which margins are diluted. This is a recurring near-term risk to the Medi Assist stock prediction.
Regulatory and Price Cap Risk
Government-mandated price caps on medical procedures affect hospital revenues and can compress the Medi Assist stock forecast.
Competition
New hospital chains expanding into metro and tier 2 cities create competitive pressure on occupancy and billing, which is a recurring caution in the Medi Assist share price prediction.
Medical Cost Inflation
Rising manpower and consumables costs affect EBITDA margins and the Medi Assist stock forecast. Cost risk is reflected in the width of the Medi Assist share price prediction range.
How to Monitor the Medi Assist Stock Forecast
Track the Medi Assist share price prediction consensus quarterly. After every earnings release, most brokerages revise their Medi Assist stock forecast within two weeks. Comparing the revised analyst target to the previous estimate tells you whether sentiment on Medi Assist is improving or deteriorating.
Compare the current price of Rs 365.2 with the analyst target range of Rs 438 to Rs 404. A wide target band reflects genuine uncertainty on Medi Assist, so position size should reflect that range rather than the midpoint alone.
Review the Medi Assist share price prediction every quarter against key business metrics for the Healthcare Services and Hospitals sector. A single estimate from any analyst is a point-in-time view and should be treated as one input among many when making any investment decision.
Check Live Medi Assist Fundamentals on the Univest Screener
Conclusion
The Medi Assist stock prediction for 2026 reflects the analyst community’s assessment of Medi Assist Healthcare Services’s competitive position, earnings trajectory and macro environment. JM Financial holds a Buy stance with a target of Rs 438 while ICICI Securities has a Neutral rating with a target of Rs 404, giving an analyst consensus of Rs 421.
The Medi Assist stock forecast is set against near-term risks that make the Medi Assist share price prediction range wide. Investors should verify any estimate with the latest brokerage reports before using it as an investment reference. The analyst forecast will be revised after every quarterly result, so tracking how the Medi Assist share price target changes over time is more valuable than relying on any single estimate.
Investments in securities are subject to market risk. This content is for educational purposes only and does not constitute investment advice.
Download the Univest iOS App or Univest Android App to track live analyst targets, price movements and research updates for Medi Assist in real time.
Disclaimer: Data and figures in this article are sourced from publicly available information and may or may not be accurate. Analyst price targets are from public brokerage reports and should be independently verified. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions on Medi Assist Stock Prediction 2026
What is the Medi Assist stock prediction for 2026?
Ans. The Medi Assist stock prediction for 2026 is based on analyst consensus from JM Financial and ICICI Securities. The consensus target is Rs 421. All estimates may or may not be achieved.
Is the Medi Assist stock prediction bullish or bearish?
Ans. JM Financial has a Buy rating with target Rs 438. ICICI Securities has a Neutral rating with target Rs 404. The Medi Assist stock forecast reflects genuine analyst diversity of opinion.
What is the Medi Assist share price prediction based on fundamentals?
Ans. The Medi Assist share price prediction rests on the bed addition pipeline, occupancy trend, revenue per bed and EBITDA margin maturity. Analysts tracking Medi Assist closely cite these as the primary drivers of the 2026 outlook.
What is the long-term Medi Assist stock prediction?
Ans. The long-term outlook assumes Medi Assist sustains its core business drivers over a multi-year horizon. The 12-month consensus of Rs 421 is the nearest reliable anchor point.
What are the key risks to the Medi Assist stock prediction?
Ans. The primary risks include sector-specific headwinds, macro uncertainty, regulatory changes and competitive pressure. Every analyst estimate for Medi Assist should be read alongside its risk assumptions.
What does the Medi Assist stock forecast say for 2026?
Ans. JM Financial: Buy target Rs 438. ICICI Securities: Neutral target Rs 404. These Medi Assist share price prediction estimates may or may not prove accurate.
Where can I track the latest Medi Assist stock prediction?
Ans. Track the latest analyst targets and price movements for Medi Assist on the NSE and BSE websites and on the Univest app and screener for live data.
Recent Articles

Why Is Kirloskar Brothers Share Price Falling Key Reasons 2026
19 June 2026

Why Is Kothari Products Share Price Falling Key Reasons 2026
19 June 2026

Why Is Kirloskar Oil Engines Share Price Falling Key Reasons 2026
19 June 2026

Why Is Kriti Industries India Share Price Falling Key Reasons 2026
19 June 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Why Is Kirloskar Brothers Share Price Falling Key Reasons 2026
Why Is Kothari Products Share Price Falling Key Reasons 2026
Why Is Kirloskar Oil Engines Share Price Falling Key Reasons 2026
Why Is Kriti Industries India Share Price Falling Key Reasons 2026
Why Is Krebs Biochemicals and Industries Share Price Falling Key Reasons 2026
Popular this week
Why Is Kirloskar Brothers Share Price Falling Key Reasons 2026
Why Is Kothari Products Share Price Falling Key Reasons 2026
Why Is Kirloskar Oil Engines Share Price Falling Key Reasons 2026
Why Is Kriti Industries India Share Price Falling Key Reasons 2026
Why Is Krebs Biochemicals and Industries Share Price Falling Key Reasons 2026

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas





